Akinchan Bhardwaj: Exercise Biological Modifier of Vascular Trajectory
Akinchan Bhardwaj, Consultant Interventional Cardiologist at Kauvery Hospital, shared a post on LinkedIn:
“If exercise were a drug, we would call it multi-target vascular therapy.
Exercise is often framed as ‘cardiovascular risk reduction.’ But that description undersells what it actually does.
Exercise is not simply a statistical modifier of event probability.
It is a biological modifier of vascular trajectory.
Regular physical activity has been shown to:
- Improve endothelial nitric oxide bioavailability
- Reduce systemic inflammatory tone
- Enhance insulin sensitivity independent of weight loss
- Improve autonomic balance and blood pressure variability
- Influence plaque phenotype toward more stable morphology
Most pharmacologic therapies act on a single pathway.
Exercise simultaneously influences lipid metabolism, inflammation, metabolic pressure and vascular function.
If cardiovascular risk is a curve, exercise does not just shift it downward. It reduces its slope.
That distinction matters as we rethink prevention in an era of genomics, AI and precision risk modeling.
I explore this in my latest CardioForesight essay:
‘Exercise Doesn’t Just Lower Risk, It Changes Vascular Biology.'”
Stay updated with Hemostasis Today.
-
Sep 25, 2026, 13:32Gevorg Yaghjyan: Low Drug Levels, Higher Cardiovascular Risk in Lupus
-
Sep 25, 2026, 12:53Bastu Odoka: What Happened to Blood Donation?
-
Sep 25, 2026, 12:43Thomas Dayspring: Reshaping the Biology of Atherosclerotic Plaques with New Therapies
-
Sep 25, 2026, 12:14Garima Sharma: Community Clinical Linkages for Better Postpartum Cardiovascular Care
-
Sep 25, 2026, 10:49Shefina S: From Presenting to Hosting at TRANSCON 2026
-
Sep 25, 2026, 10:37Michelle Leona Cecil: Hemophilia Advocacy and the Power of Community
-
Sep 25, 2026, 10:13Michael Baria: Platelet Concentration and PRP Outcomes in Partial Rotator Cuff Tears
-
Sep 25, 2026, 08:55Hitarth Mehta: BHMS Students Gain Practical Exposure to Haemophilia Diagnosis
-
Sep 25, 2026, 07:25Varun Capoor: How Therapeutic Apheresis and Transfusion Medicine Can Complement Clinical Management in SCD